Home LiteratureArticle Details
PMID: 10217645 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events.

Circulation ·Vol. 99 ·No. 16 ·1999-04-27 ·Pages 2079-84

Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, Dinarello CA, Maseri A

Abstract

A growing body of evidence suggests a role for inflammation in acute coronary syndromes. The aim of this study was to assess the role of proinflammatory cytokines, their time course, and their association with prognosis in unstable angina. We studied 43 patients aged 62+/-8 years admitted to our coronary care unit for Braunwald class IIIB unstable angina. In each patient, serum levels of interleukin-1 receptor antagonist (IL-1Ra), interleukin-6 (IL-6) (which represent sensitive markers of biologically active IL-1beta and tumor necrosis factor-alpha levels, respectively), and troponin T were measured at entry and 48 hours after admission. Troponin T-positive patients were excluded. Patients were divided a posteriori into 2 groups according to their in-hospital outcome: group 1 comprised 17 patients with an uneventful course, and group 2 comprised 26 patients with a complicated in-hospital course. In group 1, mean IL-1Ra decreased at 48 hours by 12%, and IL-6 diminished at 48 hours by 13%. In group 2, IL-1Ra and IL-6 entry levels were higher than in group 1 and increased respectively by 37% and 57% at 48 hours (P<0.01). These findings indicate that although they receive the same medical therapy as patients who do not experience an in-hospital event, patients with unstable angina and with complicated in-hospital courses have higher cytokine levels on admission. A fall in IL-1Ra and IL-6 48 hours after admission was associated with an uneventful course and their increase with a complicated hospital course. These findings may suggest novel therapeutic approaches to patients with unstable angina.

MeSH Terms
Angina, Unstable/blood,immunology Biomarkers/blood Coronary Care Units Coronary Disease/blood,epidemiology,immunology Female Hospitalization Humans Inpatients Interleukin 1 Receptor Antagonist Protein Interleukin-1/blood Interleukin-6/blood Male Middle Aged Receptors, Interleukin-1/antagonists & inhibitors Risk Factors Sensitivity and Specificity Sialoglycoproteins/blood Time Factors Troponin T/blood Tumor Necrosis Factor-alpha/analysis,metabolism
Chemicals
Biomarkers IL1RN protein, human Interleukin 1 Receptor Antagonist Protein Interleukin-1 Interleukin-6 Receptors, Interleukin-1 Sialoglycoproteins Troponin T Tumor Necrosis Factor-alpha
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Biasucci L M
Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy. [email protected]
Liuzzo G
Fantuzzi G
Caligiuri G
Rebuzzi A G
Ginnetti F
Dinarello C A
Maseri A
Article Info
Journal
Circulation
Abbr.
Circulation
ISSN
1524-4539
Published
1999-04-27
Pages
2079-84
Language
English
Region
United States
NLM ID
0147763
Subset
IM
Grants
NIAID NIH HHS · AI-15614 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]